Share This Story  |   Comments (0)

Medical devices

Pelikan
Pelikan Technologies Inc. of Palo Alto, Calif., has raised $69 million in a new round of funding. The company has developed an approved device for electronically extracting blood samples for glucose monitoring in diabetics. The six-year-old company has raised $145 million in venture capital. Clarus Ventures of South San Francisco, Calif., led the round, joined by new investors Bio*One Capital Pte. Ltd. of Singapore and Global Life Science Ventures of Switzerland. Also participating were the returning HBM BioVentures AG of Switzerland, and Mannheim Holdings LLC of New York. The funds allow Pelikan to complete development and launch marketing of its integrated monitoring product.

CardioMEMS
Wireless heart monitor developer CardioMEMS Inc. has raised $33 million in Series E financing. It will use the capital to complete regulatory development and launch the product. The devices is targeted at aneurysm patients and the larger heart failure market. Arcapita Ventures of Atlanta led the round, along with other new investors Deerfield Capital Management of Boston, Vision Capital Advisors of Burlingame, Calif., Aperture Venture Partners LLC of New York and Rockport Venture Securities of Boston. Insiders included Boston Millennia Partners of Boston, Medtronic Inc. of Minneapolis, Easton Capital Partners LP of New York, Foundation Medical Partners of Rowayton, Conn., and Arboretum Ventures of Ann Arbor, Mich. Total investment in the Atlanta-based company is more than $85 million. --Clifford Carlsen

Informatics

Gene Security Network
Molecular diagnostics company Gene Security Network Inc. has closed a $4 million Series A financing. Led by Claremont Creek Ventures of Oakland, Calif. Also participating were Sequoia Capital of Menlo Park, Calif., Huntington Reproductive Center and private investor Marissa Mayer, a VP of Search Products and User Experience at Google Inc. The Portola Valley, Calif., company's molecular diagnostics technology uses data informatics to enhance genetic testing, allowing accurate testing for multiple genetic diseases from a single cell. GSN will use the capital to commercialize its genetic screening technology.

Software

Adomo
Cupertino, Calif., unified messaging software maker Adomo Inc. raised $15 million Series A-1 funding round led by existing investors Menlo Ventures and Storm Ventures, both of Menlo Park, Calif. The company will use the money to expand product development, sales and marketing of products that integrate data networks and telephony using existing infrastructure such as standard PBX systems or Microsoft Exchange servers. Adomo aims to allow its customers to deploy Internet Protocol telephony systems faster with less cost and higher reliability, and has been backed by Menlo and Storm since 2005. -- Clifford Carlsen
   
Verical
Verical Inc. of Alexandria, Va., a provider of supply-chain security software, has raised a $3.2 million Series A round. The capital came from Valhalla Partners of Vienna, Va., and will be used for sales and operations expansion. The company's software is targeted at global manufacturers that want to protect against counterfeit parts, and other types of  fraud encountered in international trade. --G.W.

---

Post a comment

Name:

Email Address:

URL:

Remember personal info?

Comments: (you may use HTML tags for style)

Please only click "Post" once. It may take a few moments to process.